Skip to main content
Equibles

FMR LLC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 315066 BOSTON, MA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,221
-$6,348 QoQ
Shares Held
2,151
+18.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. LYEL ranks #289 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,221 2,151
2026-03-31 $36,569 1,823
2025-12-31 $56,296 1,829
2025-09-30 $44,204 2,722
2025-06-30 $27,200 3,077
2025-03-31 $10,401 19,335
2024-12-31 $10,300 16,095
2024-09-30 $1,413,924 1,024,583
2024-06-30 $3,963,519 2,733,462
2024-03-31 $6,175,453 2,769,262
2023-12-31 $5,410,128 2,788,727
2023-09-30 $4,185,716 2,847,426
2023-06-30 $9,108,944 2,864,448
2023-03-31 $6,915,283 2,930,205
2022-12-31 $10,310,656 2,971,371
2022-09-30 $24,149,629 3,294,629
2022-06-30 $18,265,981 2,801,531
2022-03-31 $12,535,731 2,482,323
2021-12-31 $8,223,385 1,062,453
2021-09-30 $5,613,639 379,300
2021-06-30 $4,014,528 247,200